MacroGenics
MGNX
#8706
Rank
S$0.30 B
Marketcap
S$4.73
Share price
-2.38%
Change (1 day)
132.35%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): S-$1.99

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$1.96. In 2025 the company made an earnings per share (EPS) of S-$1.51 a decrease over its 2024 EPS that were of S-$1.37.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.9931.83%
2025S-$1.5110.28%
2024S-$1.37613.33%
2023S-$0.19-92.31%
2022S-$2.50-42.14%
2021S-$4.3236.44%
2020S-$3.17-21.84%
2019S-$4.05-24.58%
2018S-$5.37675.93%
2017S-$0.69-68.05%
2016S-$2.17168.25%
2015S-$0.81-55%
2014S-$1.793400%
2013S-$0.05127-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.68-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.18-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.56-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.51-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.58-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.56-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.94 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA